GlobalData’s detailed strategic reports on the MFN executive order and on the GENEROUS model examined how some of the known adverse effects of IRP will be unleashed.
The Centers for Medicare and Medicaid Services ("CMS") recently proposed GLOBE (Part B) and GUARD (Part D) mandatory drug pricing initiatives designed to incorporate a most-favored-nation ("MFN") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results